SAB Biotherapeutics reported total assets of $238.21M and total liabilities of $23.43M for the quarter ended Jun 2026, up 690.6% year over year. This balance sheet covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 3.22M | 3.76M | 4.51M | 5.38M | 6.28M | 8.99M | 9.91M | 11.87M | 12.91M | 13.85M | 14.57M | 15.32M | 16.08M | 16.82M | 17.52M | 18.12M | 18.75M | ||||||
| Receivables - AccuredAcc. Int. Receivables | 0.19M | 0.23M | 0.10M | 0.10M | 0.02M | 0.56M | 0.95M | 1.60M | 1.84M | ||||||||||||||
| Assets | |||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 10.75M | 33.21M | 22.41M | 16.62M | 8.33M | 15.05M | 13.06M | 7.77M | 2.43M | 56.57M | 14.03M | 17.24M | 9.20M | 8.90M | 5.64M | 3.69M | 29.42M | 10.50M | 20.52M | 8.27M | |||
| Receivables - NetNet Receivables | 8.01M | 11.79M | 9.61M | 12.94M | 5.56M | 0.76M | 0.36M | ||||||||||||||||
| Receivables | 8.01M | 11.79M | 9.61M | 12.94M | 5.56M | 0.76M | 0.36M | ||||||||||||||||
| Prepaid Assets | 0.10M | 2.64M | 2.99M | 1.77M | 0.91M | 1.49M | 1.21M | 0.87M | 0.70M | 2.34M | 2.70M | 2.03M | 2.04M | 2.98M | 3.42M | 3.59M | 1.84M | 3.51M | 3.84M | 3.46M | |||
| Current Assets | 0.77M | 50.19M | 37.18M | 28.00M | 22.18M | 22.10M | 15.03M | 9.01M | 3.13M | 58.91M | 46.95M | 39.58M | 32.54M | 23.79M | 16.30M | 9.31M | 113.28M | 101.05M | 112.78M | 107.94M | |||
| Non-Current Assets | |||||||||||||||||||||||
| Construction in Progress | 4.61M | 0.31M | 0.33M | ||||||||||||||||||||
| Property, Plant & Equipment (Net) | 24.31M | 24.97M | 24.84M | 24.03M | 23.25M | 22.37M | 21.53M | 20.62M | 19.74M | 17.90M | 16.92M | 16.08M | 15.37M | 14.61M | 13.86M | 13.11M | 13.31M | 13.81M | 14.23M | ||||
| Long-Term Investments | 116.16M | 1.24M | 50.61M | 46.89M | 110.24M | 105.35M | |||||||||||||||||
| Other Non-Current Assets | 13.10M | ||||||||||||||||||||||
| Non-Current Assets | 116.16M | 30.95M | 31.30M | 31.40M | 30.33M | 28.81M | 27.64M | 26.44M | 25.21M | 25.03M | 24.42M | 22.31M | 21.26M | 20.40M | 21.82M | 20.82M | 70.17M | 71.76M | 135.69M | 130.27M | |||
| Assets | 116.93M | 81.14M | 68.49M | 59.41M | 52.51M | 50.90M | 42.67M | 35.44M | 28.34M | 83.94M | 71.37M | 61.89M | 53.80M | 44.20M | 38.12M | 30.13M | 183.45M | 172.81M | 248.47M | 238.21M | |||
| Liabilities | |||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||
| Accounts Payables | 4.46M | 4.98M | 4.94M | 5.48M | 3.68M | 1.44M | 1.40M | 1.08M | 0.95M | 1.24M | 1.17M | 1.30M | 1.69M | 2.52M | 2.62M | 2.95M | 3.15M | 3.54M | 3.85M | ||||
| Notes Payables | 1.80M | 1.04M | 0.28M | 0.03M | 0.77M | 0.44M | 0.11M | 0.54M | 1.05M | 0.84M | 0.62M | 0.28M | 0.14M | ||||||||||
| Payables | 6.26M | 6.02M | 5.22M | 5.51M | 4.45M | 1.89M | 1.52M | 1.62M | 2.00M | 2.08M | 1.79M | 1.30M | 1.97M | 2.66M | 2.62M | 2.95M | 3.15M | 3.54M | 3.85M | ||||
| Accumulated Expenses | 0.32M | 12.46M | 11.86M | 9.86M | 10.24M | 9.92M | 8.19M | 5.93M | 5.30M | 6.69M | 5.17M | 5.05M | 6.88M | 5.47M | 6.06M | 7.09M | 6.85M | 6.58M | 5.39M | 7.21M | |||
| Other Accumulated Expenses | 0.28M | 0.34M | 0.34M | 0.25M | 0.51M | 0.20M | 0.27M | 0.21M | 0.48M | 0.64M | 0.22M | 1.70M | 0.52M | 0.74M | 0.81M | 1.62M | 0.85M | 1.01M | 1.60M | ||||
| Current Leases | 1.14M | 1.15M | 1.17M | 1.21M | 0.49M | 0.52M | 0.55M | 0.53M | 0.67M | 0.54M | 0.46M | 0.38M | 0.39M | 0.79M | 0.82M | 0.84M | 0.80M | 0.76M | 0.48M | ||||
| Current Taxes | 0.09M | ||||||||||||||||||||||
| Current Deferred Revenue | 0.10M | 2.94M | 2.89M | 1.63M | 1.32M | 0.38M | 0.11M | 0.11M | |||||||||||||||
| Total Current Liabilities | 0.32M | 26.46M | 19.27M | 16.39M | 17.10M | 14.99M | 13.67M | 11.01M | 9.21M | 10.81M | 8.30M | 7.55M | 8.82M | 7.98M | 9.65M | 10.68M | 10.79M | 10.68M | 9.85M | 11.71M | |||
| Non-Current Liabilities | |||||||||||||||||||||||
| Capital Leases | 3.76M | 3.73M | 3.69M | 3.66M | 3.63M | 3.60M | 3.49M | 3.45M | 3.42M | 3.38M | 3.35M | 3.31M | 3.28M | 3.24M | 3.20M | 3.16M | 3.12M | 3.08M | 3.04M | ||||
| Non-Current Debt | 1.80M | 0.54M | |||||||||||||||||||||
| Convertible Debt | 0.54M | 0.54M | 0.54M | ||||||||||||||||||||
| Non-Current Deffered Revenue | -4.22M | ||||||||||||||||||||||
| Preferred Stock Liabilities | 116.15M | ||||||||||||||||||||||
| Operating Leases | 2.80M | 1.36M | 1.06M | 0.76M | 0.36M | 0.75M | 0.64M | 0.64M | 0.55M | 0.78M | 0.68M | 0.58M | 2.47M | 2.26M | 2.04M | 1.88M | 2.17M | 1.45M | |||||
| Other Non-Current Liabilities | 5.53M | 10.72M | 2.87M | 1.14M | 0.36M | 0.32M | 0.24M | 0.60M | 0.42M | 11.77M | 6.31M | 4.09M | 4.08M | 6.39M | 1.35M | 1.98M | 2.38M | 5.63M | 6.12M | 7.23M | |||
| Total Non-Current Liabilities | 4.54M | 31.87M | 24.36M | 21.15M | 21.53M | 19.53M | 18.03M | 15.13M | 12.66M | 14.87M | 12.24M | 11.68M | 12.81M | 11.84M | 15.36M | 16.13M | 15.99M | 15.68M | 15.10M | 16.20M | |||
| Total Liabilities | 10.07M | 42.59M | 27.23M | 22.29M | 21.88M | 19.85M | 18.27M | 15.73M | 13.08M | 26.64M | 18.55M | 15.77M | 16.89M | 18.23M | 16.71M | 18.11M | 18.37M | 21.32M | 21.22M | 23.43M | |||
| Shareholder's Equity | |||||||||||||||||||||||
| Total Debt | 3.59M | 1.04M | 0.28M | 0.03M | 1.31M | 0.44M | 0.11M | 0.54M | 1.05M | 0.84M | 0.62M | 0.28M | 0.14M | ||||||||||
| Common Equity | 35.08M | 38.55M | 41.26M | 37.12M | 30.62M | 31.06M | 24.40M | 19.72M | 15.26M | 57.30M | 52.82M | 46.12M | 36.90M | 25.97M | 21.41M | 12.02M | 165.07M | 151.50M | 227.25M | 214.78M | |||
| Liabilities and Shareholders Equity | 116.93M | 81.14M | 68.49M | 59.41M | 52.51M | 50.90M | 42.67M | 35.44M | 28.34M | 83.94M | 71.37M | 61.89M | 53.80M | 44.20M | 38.12M | 30.13M | 183.45M | 172.81M | 248.47M | 238.21M | |||
| Treasury Shares | 0.55M | 0.55M | 0.55M | 0.05M | 0.55M | 0.55M | 0.55M | -0.05M | -0.05M | -0.05M | -0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | 0.05M | |||||
| Retained Earnings | -9.29M | 67.67M | 74.92M | 75.56M | 76.14M | 84.45M | 85.14M | 87.34M | 87.98M | 152.86M | 153.49M | 154.10M | 155.14M | 155.79M | 156.41M | 157.03M | 264.55M | 267.72M | 362.75M | 373.48M | |||
| Preferred Shares | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 64.00 | 59.00 |